Editor’s introduction to the initial issue of the fourth volume of GaBI Journal

Author(s): Professor Philip D Walson, MD

This first 2015 GaBI Journal issue (fourth volume of the journal) is being published soon after the first US biosimilar approval and it contains a number of articles that illustrate how the development, marketing and acceptance of biosimilars differ globally including in North and South America and the Persian Gulf States. An Editorial entitled Biosimilars: […]

Read more →